Labcorp Holdings Inc. LH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 14.59B | 14.35B | 14.14B | 13.95B | 13.77B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.59B | 14.35B | 14.14B | 13.95B | 13.77B |
| Cost of Revenue | 10.37B | 10.20B | 10.07B | 9.94B | 9.85B |
| Gross Profit | 4.23B | 4.14B | 4.08B | 4.01B | 3.92B |
| SG&A Expenses | 2.29B | 2.23B | 2.23B | 2.23B | 2.27B |
| Depreciation & Amortization | 305.00M | 295.80M | 286.00M | 280.00M | 277.80M |
| Other Operating Expenses | 2.50M | -- | -- | -- | -- |
| Total Operating Expenses | 12.96B | 12.73B | 12.59B | 12.45B | 12.40B |
| Operating Income | 1.63B | 1.62B | 1.56B | 1.50B | 1.36B |
| Income Before Tax | 1.22B | 1.23B | 1.15B | 1.11B | 1.10B |
| Income Tax Expenses | 219.60M | 230.20M | 209.30M | 229.80M | 244.30M |
| Earnings from Continuing Operations | 1.01K | 1.00K | 942.70 | 877.70 | 856.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.10M | -1.20M | -1.20M | -1.20M | -1.20M |
| Net Income | 1.00B | 1.00B | 941.50M | 876.50M | 855.20M |
| EBIT | 1.63B | 1.62B | 1.56B | 1.50B | 1.36B |
| EBITDA | 2.34B | 2.32B | 2.25B | 2.19B | 2.05B |
| EPS Basic | 12.27 | 12.17 | 11.37 | 10.54 | 10.26 |
| Normalized Basic EPS | 10.53 | 10.48 | 9.80 | 9.42 | 8.53 |
| EPS Diluted | 12.18 | 12.08 | 11.28 | 10.45 | 10.19 |
| Normalized Diluted EPS | 10.47 | 10.41 | 9.73 | 9.35 | 8.47 |
| Average Basic Shares Outstanding | 327.60M | 329.60M | 331.30M | 332.60M | 333.70M |
| Average Diluted Shares Outstanding | 329.70M | 331.80M | 333.70M | 335.10M | 336.10M |
| Dividend Per Share | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 |
| Payout Ratio | 23.65% | 23.86% | 25.52% | 27.46% | 28.24% |